
SmileDirectClub SDC
Quarterly report 2023-Q2
added 08-08-2023
SmileDirectClub Operating Income 2011-2026 | SDC
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income SmileDirectClub
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -262 M | -259 M | -217 M | -490 M | -45.6 M | -30.5 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -30.5 M | -490 M | -218 M |
Quarterly Operating Income SmileDirectClub
| 2023-Q2 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -45 M | - | -62.3 M | -55 M | -71.7 M | -93.2 M | -85 M | -53.2 M | -27.8 M | -19.2 M | -27.8 M | -74 M | -96.5 M | -92.2 M | -382 M | 685 K | -16.4 M | -22.8 M | -3.73 M | -1.64 M | -17.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 685 K | -382 M | -62.3 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | ||
|
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | ||
|
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | ||
|
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | ||
|
Abbott Laboratories
ABT
|
8.05 B | $ 102.58 | -0.28 % | $ 179 B | ||
|
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | ||
|
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M | ||
|
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | ||
|
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
90.9 M | $ 12.17 | 1.16 % | $ 1.64 B | ||
|
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | ||
|
Align Technology
ALGN
|
608 M | $ 172.16 | 0.91 % | $ 12.9 B | ||
|
Apyx Medical Corporation
APYX
|
-6.45 M | $ 3.88 | 5.43 % | $ 159 M | ||
|
Alphatec Holdings
ATEC
|
-82.1 M | $ 10.93 | 0.92 % | $ 1.64 B | ||
|
AxoGen
AXGN
|
-7.85 M | $ 33.66 | -2.26 % | $ 1.55 B | ||
|
Butterfly Network
BFLY
|
-74.4 M | $ 4.1 | -0.36 % | $ 868 M | ||
|
Bruker Corporation
BRKR
|
253 M | $ 36.75 | -0.03 % | $ 5.48 K | ||
|
Boston Scientific Corporation
BSX
|
3.61 B | $ 63.21 | 0.62 % | $ 93.6 B | ||
|
ClearPoint Neuro
CLPT
|
-24.2 M | $ 9.53 | 1.71 % | $ 270 M | ||
|
CONMED Corporation
CNMD
|
103 M | $ 34.78 | -0.03 % | $ 1.08 B | ||
|
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.6 | 2.92 % | $ 37.3 M | ||
|
Delcath Systems
DCTH
|
660 K | $ 9.72 | 0.88 % | $ 348 M | ||
|
EDAP TMS S.A.
EDAP
|
-19.8 M | $ 3.56 | 5.0 % | $ 133 M | ||
|
Electromed
ELMD
|
9.66 M | $ 23.59 | 1.29 % | $ 199 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 81.57 | 0.64 % | $ 47.7 B | ||
|
FONAR Corporation
FONR
|
5.31 M | $ 18.56 | -0.16 % | $ 122 M | ||
|
NanoVibronix
NAOV
|
-3.58 M | - | - | $ 1.08 M | ||
|
Globus Medical
GMED
|
480 M | $ 87.65 | -0.31 % | $ 11.9 B | ||
|
Helius Medical Technologies
HSDT
|
-12.4 M | $ 1.97 | 5.65 % | $ 1.2 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 9.4 | -1.36 % | $ 724 M | ||
|
Inogen
INGN
|
-30.2 M | $ 6.46 | 4.03 % | $ 172 M | ||
|
Inspire Medical Systems
INSP
|
51 M | $ 56.86 | 3.4 % | $ 1.67 B | ||
|
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.01 | 3.09 % | $ 17.1 M |